Global Antibiotic Market: Overview
An Antibiotic, also sometimes termed as antibacterial, is a compound that negotiates and neutralizes bacterial infections, by killing them or minimizing their growth. Since penicillin, one of the first antibiotics that was made in 1920s, numerous compounds have been discovered and have been highly useful. But, several pathogens have also evolved and now have become resistant to commonly used antibiotics, which has led to a revival in the antibiotics sector. While some companies are developing analogues of existing antibiotic classes, others are into the process of developing molecules that adapt new approaches to tackle the bacterial infections. Consequently, the global antibiotic market is projected for a healthy growth rate during the forecast period of 2016 to 2024.
For Any Queries Get Solutions With A PDF Sample : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=590
This report on global market for antibiotic is a comprehensive analysis of all the factors that may influence the growth rate over the course of next few years, and presents figurative estimations. It also profiles some of the key companies currently operational in this sector, evaluating their market share, product portfolio, and recent developments. Besides studying the lucrativeness of regional markets, the report also segments the global antibiotic market on the basis of product and application. By product, the market can be divided into beta-lactams, fluoroquinolones, macrolides, tetracycline, and other antibiotic classes. The segment of beta-lactams can be further sub-segmented into penicillin, cephalosporins, and carbapenems, while fluoroquinolones can be divided into second generation, third generation, and others. By application, the market can be divided into human applications and veterinary applications.
Global Antibiotic Market: Trends and Opportunities
Escalated efforts towards the development of advanced products is observed by the report as the primary driver in the global antibiotic market. As per the Pew Charitable Trust, nearly 37 propitious molecules were under development in March 2016 in the U.S. alone. Several of these are in phase II clinical trials, with a target to reach the market mid-way through the forecast period. Additionally, helpful government legislations such as the Generating Antibiotics Incentives Now (GAIN) Act are also encouraging research and development processes, and thereby expanding the market’s horizon.
The continuous increase of infectious diseases across the globe and the current gap in demand and supply of antibiotics are other two prominent factors that are favoring the market. Strategic collaborations to divide the expenses of research and development process is now fairly common among the biotechnology companies, which is leading to a surge in the number of prospect molecules. Conversely, the development of resistance by the pathogens, particularly in case of bacterial infections, is expected to critically impact the antibiotic market. According to a report by the Centers for Disease Control and Prevention (CDC) in 2014, about two million people are affected by antibiotic resistance development annually, out of which nearly 23,000 eventually die.
Global Antibiotic Market: Region-wise Outlook
Geographically, the report studies the regional antibiotic markets of North America, Europe, Asia Pacific, and rest of the world. Owing to factors such as vast population, high prevalence of infectious diseases, regulation reforms, and incremented use of generic medicines, Asia Pacific currently accounts for the widest market for antibiotic. The outbreak of Ebola is expected to propel market prospects in the African region.
View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/antibiotic-market.html
Companies mentioned in the research report
Some of the prominent players currently functional in global antibiotic market are Pfizer Inc., Roche, Astellas Pharma, Inc, Novartis AG, Bayer HealthCare AG, Bristol-Myers Squibb Co., MiddleBrook Pharmaceuticals, Abbott Laboratories, Daiichi Sankyo Company, Ltd., Takeda Pharmaceutical Company, Ltd., Eli Lilly and Co., Cubist Pharmaceuticals, Inc., GlaxoSmithKline Plc, Kyorin Pharmaceutical Co., Ltd, Johnson & Johnson, LG Life Sciences Limited, Inc, Pliva d.d., Sanofi-Aventis SA, and Toyama Chemical Co., Ltd.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453